NCT06959810 Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management
| NCT ID | NCT06959810 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Francois Baclesse |
| Condition | Oncology |
| Study Type | INTERVENTIONAL |
| Enrollment | 55 participants |
| Start Date | 2025-10-24 |
| Primary Completion | 2027-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 55 participants in total. It began in 2025-10-24 with a primary completion date of 2027-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image. Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive. This study will assess the feasibility of oncoesthetics and describe any obstacles.
Eligibility Criteria
Inclusion Criteria: * Patient aged 18 or over * Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus. * Patient due to start oncological treatment (recurrence authorized) * Patient fluent in French. * Affiliation with a social security scheme * Signature of informed consent prior to any specific procedure linked to the study * Treatment with curative intent Exclusion Criteria: * Breast-feeding or pregnant patient * Any associated medical or psychological condition that could compromise the patient's ability to participate in the study * Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent. * Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06959810 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Oncology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06959810 currently recruiting?
Yes, NCT06959810 is actively recruiting participants. Contact the research team at m.renou@baclesse.unicancer.fr for enrollment information.
Where is the NCT06959810 trial being conducted?
This trial is being conducted at Caen, France.
Who is sponsoring the NCT06959810 clinical trial?
NCT06959810 is sponsored by Centre Francois Baclesse. The trial plans to enroll 55 participants.